Stockholm, Sweden

Padraig D'Arcy

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Padraig D'Arcy

Introduction

Padraig D'Arcy is a notable inventor based in Stockholm, Sweden. He has made significant contributions to the field of biochemistry, particularly in the area of proteasome inhibitors. His work has implications for various therapeutic applications, showcasing the importance of innovation in scientific research.

Latest Patents

D'Arcy holds a patent for a method titled "Protease deubiquitinating inhibitor screening." This innovative method involves screening a compound to determine whether it acts as a proteasome deubiquitinating inhibitor of high specificity. The process includes contacting the compound with human 19S regulatory particles of the 26S proteasome and assessing its ability to inhibit the activity of deubiquitinating enzymes UCHL5 and USP14. A successful inhibition of these enzymes indicates that the compound is a highly specific proteasome deubiquitinating inhibitor. He has 1 patent to his name.

Career Highlights

D'Arcy is currently employed at Vivolux AB, where he continues to advance his research and development efforts. His work at the company reflects his commitment to innovation and the application of scientific knowledge to real-world problems.

Collaborations

Some of his notable coworkers include Slavica Brnjic and Rolf Larsson, who contribute to the collaborative environment that fosters innovation at Vivolux AB.

Conclusion

Padraig D'Arcy's contributions to the field of biochemistry through his innovative patent demonstrate the vital role of inventors in advancing scientific knowledge. His work not only highlights his expertise but also the collaborative efforts that drive progress in research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…